 |
|
|
| |
Asunaprevir With Peginterferon-Alfa and Ribavirin in Treatment-Naive Patients With Genotype-1 or -4
Chronic Hepatitis C: SVR24 Results From a Randomized Phase 2b Study (AI447-016)
|
| |
| |
Reported by Jules Levin
EASL 2013 Amsterdam April 26
Bronowicki J-P,1 Ratziu V,2 Gadano A,3 Thuluvath PJ,4 Bessone F,5 Martorell CT,6 Pol S,7 Terg R,8 Younes Z,9 He B,10 Eley T,10 Cohen D,11 Mendez P,10 Hughes EA10
1Centre Hospitalier Universitaire de Nancy, Université de Lorraine, Vandoeuvre les Nancy, France; 2Groupe Hospitalier Pitié Salpêtrière, Paris, France; 3Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; 4Mercy Medical Center, Baltimore, MD, USA;
5Hospital Provincial del Centenario, University of Rosario School of Medicine, Rosario, Argentina; 6The Research Institute, Springfield, MA, USA; 7Université Paris Descartes, Hôpital Cochin, Paris, France; 8Universidad del Salvador Hospital de Gastroenterología Bonorino Udaondo,
Buenos Aires, Argentina; 9Gastro One, Germantown, TN, USA; 10Bristol-Myers Squibb, Princeton, NJ, USA; 11Bristol-Myers Squibb, Wallingford, CT, USA
|
| |
|
|
|
|
|
